GEN Exclusives

More »

GEN News Highlights

More »
Sep 28, 2006

Pharmacopeia and Schering-Plough Extend Collaboration

  • Pharmacopeia and Schering-Plough extended their collaboration until April of 2007. The terms of the extension call for Schering-Plough to continue to pay Pharmacopeia research funding for 10 full-time chemistry employees.

    Schering-Plough will also pay preclinical, clinical, and regulatory milestones as long as therapeutic candidates resulting from the collaboration advance to commercialization. Further, Pharmacopeia will continue to receive royalty payments on sales of any therapeutic products resulting from the collaboration.

    The goal of the collaboration is to deliver development-ready therapeutic candidates for the Schering-Plough pipeline. The companies agreed to extend the collaboration to continue to advance one of the ongoing programs toward this goal.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Using Pet Dogs with Cancer in Preclinical Trials

Do you agree that pet dogs with cancer should be used in early cancer drug trials?

More »